Concepedia

Recurrent gastrointestinal stromal tumor (GIST) of the stomach associated with a novel c-kit mutation after imatinib treatment

Tomoki Koyama, Hiroshi Nimura, Katsutoshi Kobayashi, Hideki Marushima, Hironori Odaira, Hirotaka Kashimura, Norio Mitsumori, Katsuhiko Yanaga

Gastric Cancer · 2006 · 14 citations · 12 references

DOIFull text

Open access

Concepts

References

12

Gain-of-Function Mutations of c- <i>kit</i> in Human Gastrointestinal Stromal Tumors

Seiichi Hirota, Koji Isozaki, Y Moriyama et al. · Science · 1998 · 4.5K citations

, , +17

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

Brian Druker, Shu Tamura, Elisabeth Buchdunger et al. · Nature Medicine · 1996 · 3.7K citations

, , +13

Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor

Heikki Joensuu, Peter Roberts‎, Maarit Sarlomo‐Rikala et al. · New England Journal of Medicine · 2001 · 2.1K citations · Full text

, , +17

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

Allan T. van Oosterom, Ian Judson, Jaap Verweij et al. · The Lancet · 2001 · 1.3K citations

, , +12

Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor

Michael C. Heinrich, Diana Griffith, Brian Druker et al. · Blood · 2000 · 1.1K citations

, , +16